Trademark: 88660331
Word
CBD 2.0
Status
Dead
Status Code
602
Status Date
Tuesday, May 25, 2021
Serial Number
88660331
Mark Type
4000
Filing Date
Friday, October 18, 2019
Abandoned Date
Wednesday, April 28, 2021

Trademark Owner History

Classifications
5 Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment and prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Dermatological pharmaceutical products; Extracts of hops for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes
CBD TWO POINT ZERO

Trademark Events
May 26, 2021
Abandonment Notice E-Mailed - Failure To Respond
May 25, 2021
Abandonment - Failure To Respond Or Late Response
May 24, 2021
Assigned To Examiner
Oct 27, 2020
Notification Of Non-Final Action E-Mailed
Oct 27, 2020
Non-Final Action E-Mailed
Oct 27, 2020
Non-Final Action Written
Sep 3, 2020
Teas/Email Correspondence Entered
Sep 2, 2020
Correspondence Received In Law Office
Sep 2, 2020
Teas Response To Office Action Received
Apr 30, 2020
Notification Of Non-Final Action E-Mailed
Apr 30, 2020
Non-Final Action E-Mailed
Apr 30, 2020
Non-Final Action Written
Apr 27, 2020
Assigned To Examiner
Nov 10, 2019
Assigned To Examiner
Oct 22, 2019
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24